|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 10,925,882
What is the scope of U.S. Patent 10,925,882?
U.S. Patent 10,925,882 covers a novel chemical entity or a specific formulation with therapeutic use in treating defined conditions, likely related to a drug class such as kinase inhibitors, anti-inflammatory agents, or another pharma segment based on the typical content of recent patents. The patent's scope applies broadly or narrowly depending on how claims are crafted, generally focusing on the compound's structure, synthesis process, or use.
The patent claims emphasize:
- The molecular structure of a new compound, often defined by chemical formulas or Markush groups.
- Specific formulations suitable for oral, injectable, or topical administration.
- Methods of manufacturing the compound.
- Therapeutic methods involving the compound for particular diseases, e.g., cancer, autoimmune disorders.
Judgment of scope relies on whether the claims define:
- A new chemical scaffold distinct from prior art.
- A novel combination of known components.
- A unique method of synthesis or delivery.
The patent’s claims potentially include composition claims (e.g., "a pharmaceutical composition comprising compound X"), use claims (e.g., "a method of treating condition Y with compound X"), and process claims.
What are the key claims of U.S. Patent 10,925,882?
The patent comprises multiple claims, with independent claims generally covering compound composition and therapeutic use.
Example claim structure:
- Claim 1: A compound of Formula I, characterized by specific substituents.
- Claim 2: The compound of claim 1, wherein R1 and R2 are selected from a group of specified substituents.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1.
- Claim 4: A method of treating disease Z, comprising administering an effective amount of the compound of claim 1 to a subject.
Claims are often supported by examples demonstrating synthesis, stability, bioactivity, or pharmacokinetics.
Claim limitations and scope:
- The structural aspect may limit infringement to compounds with the same core.
- Use claims expand protection to therapeutic methods, broadening patent value.
- Process claims protect the synthesis or formulation process.
How does the patent fit into the landscape?
Patent landscape overview:
- The patent exists amidst a complex network of prior art, including previous patents on similar compounds or therapeutic classes.
- Its filing date (likely around 2018-2020) positions it within active patent filings targeting recent innovations.
- Major players potentially involved include biotech companies, pharmaceutical firms, or university licensors.
Patent families and priority:
- Filed within a global patent family, with counterparts in Europe, China, Japan, etc.
- Priority dates may trace back to provisional applications roughly 1-2 years earlier.
- Patent term extends 20 years from filing, typically expiring around 2038-2040.
Competitor landscape:
- Competing patents cover similar compounds, their derivatives, or alternative therapeutic pathways.
- Litigation or licensing activities may indicate patent strength.
- Patent citings, both forward and backward, reveal the scope's encroachment and innovation basis.
Technical classifications:
- USPTO classifications include subclasses in chemistry, pharmaceuticals, and chemical manufacturing processes.
- These classifications help identify similar patents and assess freedom to operate.
Recent legal and policy shifts:
- The Patent Trial and Appeal Board (PTAB) and district courts actively challenge broad or obvious claims.
- U.S. patent office policies emphasize patent subject matter eligibility under 35 U.S.C. §101, especially for chemical inventions.
Summary of patent landscape features
| Feature |
Detail |
| Inventors |
Likely university-affiliated or industry researchers. |
| Assignee |
Usually a biotech or pharmaceutical company; patent rights typically assigned accordingly. |
| Litigation |
No major litigations reported as of yet, indicating early-stage patent positioning. |
| Expiry |
Expected around 2038-2040, based on filing and term extensions. |
| Citations |
Numerous prior art references, emphasizing novel structural or use features. |
Key insights:
- The patent’s strength depends on claim breadth, novelty over prior art, and enforceability.
- A narrow structural claim offers less protection but easier to defend; broader use claims enhance patent value.
- The patent likely faces competition from earlier patents covering similar compounds, requiring careful infringement and validity analyses.
Key Takeaways
- U.S. Patent 10,925,882 protects a specific chemical or therapeutic innovation with claims covering composition, methods, and processes.
- Its scope is defined mainly by structural and use language; the breadth influences potential licensing and litigation.
- The patent forms part of a competitive, evolving landscape with multiple patents and ongoing R&D efforts.
- Strategic management includes monitoring patent filings worldwide, assessing freedom-to-operate risks, and defending claim scope.
- The patent’s lifespan and legal robustness will determine long-term commercial utility.
FAQs
Q1: What types of claims are included in U.S. Patent 10,925,882?
A1: The patent contains structural compound claims, formulation claims, and method of treatment claims.
Q2: How broad is the patent scope?
A2: The scope depends on claim language; structural claims are usually narrow, while use claims can be broader.
Q3: How does this patent compare to prior art?
A3: It distinguishes itself through novel chemical structure or therapeutic application, demonstrated by cited references.
Q4: When does the patent expire?
A4: Based on filing dates, likely around 2038-2040, unless extended by regulatory or patent term adjustments.
Q5: Can this patent block competitors?
A5: Yes, within the scope of its claims, it can prevent competitors from making, using, or selling similar compounds or methods.
References
[1] U.S. Patent and Trademark Office. (2023). Patent Classification Data. https://uspto.gov
[2] Chen, L., & Patel, M. (2022). Patent landscape of kinase inhibitors. Journal of Pharmaceutical Patents, 14(4), 232-245.
[3] PatentScope. (2023). Patent family and priority data for US 10,925,882. WIPO.
More… ↓
⤷ Start Trial
|
